Blog Of The Day

Explore how decentralized clinical trials improve patient recruitment and retention through digital innovation—while a new validation model ensures data integrity, compliance, and inspection readiness.

Learn how ADAMAS ensures industry-leading data privacy and cybersecurity compliance through robust policies, secure platforms, and expert oversight—protecting clients against evolving risks.

Understand how implementing KRIs and QTLs is essential to meeting ICH E6(R2) requirements and preparing for the risk-based focus of the upcoming ICH E6(R3) revision.

Discover how ADAMAS delivers enterprise-grade QA compliance with advanced data security, privacy protocols, and a robust Quality Management System that exceeds industry standards.

Could a second, potentially more contagious wave, of COVID-19 bring further disruption to travel and clinical trial activities? Is it possible to meet the current oversight and compliance expectations of regulatory authorities? We are all aware of the initial impact...

It’s a tough choice – new drugs for patients or the health and safety of your valued staff? With ADAMAS Consulting, you do not have to choose. As we keep hearing these are unprecedented times, and just recently there have been concerning articles in the scientific...

The U.S. Food and Drug Administration has announced the retirement of the MedWatch to Manufacturer Program (MMP) as of 31st July 2020. The program provided participating drug and biologic manufacturers with a means of receiving information from the FDA on serious...

“The only constant in life is change”-Heraclitus. This cannot be truer in today’s context. In the past two decades, clinical research industry, has gone through a paradigm shift from the use of paper-based systems to web based electronic systems and from traditional...